Detalhe da pesquisa
1.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A
; 121(4): e2308942121, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38241441
2.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37384759
3.
Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.
J Virol
; 91(18)2017 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28679760
4.
Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.
J Virol
; 90(22): 10220-10235, 2016 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27581986
5.
Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility.
J Clin Microbiol
; 52(11): 4056-7, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25165081
6.
Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".
J Virol
; 92(9)2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29654221
7.
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape.
Cell Rep
; 33(8): 108430, 2020 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33238131
8.
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.
PLoS One
; 10(7): e0133869, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26218737